Chordin Knockdown Boosts Bone Cell Development
Author Information
Author(s): Kwong Francois NK, Richardson Stephen M, Evans Christopher H
Primary Institution: Center for Molecular Orthopaedics, Harvard Medical School
Hypothesis
The BMP inhibitor chordin is produced endogenously during the osteogenic differentiation of human mesenchymal stem cells (MSCs); and blockade of the activity of the BMP inhibitor increases the rate of osteogenic differentiation of human MSCs in vitro.
Conclusion
Chordin limits the bone-forming ability of human MSCs, and targeting it may enhance bone regeneration.
Supporting Evidence
- Chordin knockdown led to a significant increase in alkaline phosphatase expression.
- Calcium deposition was approximately twofold higher in chordin knockdown cells compared to controls.
- Chordin expression was not detectable in MSCs cultured in basal media.
Takeaway
Chordin is a protein that stops bone cells from growing. If we block it, the bone cells can grow better.
Methodology
Human MSCs were derived from bone marrow and induced to differentiate into bone cells using specific media, with chordin knockdown achieved through RNA interference.
Limitations
The study had a small sample size of five donors, which may limit the generalizability of the findings.
Participant Demographics
Five donors, including one 19-year-old male and four older individuals aged 71 to 78.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website